Technical Analysis for NBRV - Nabriva Therapeutics AG

Grade Last Price % Change Price Change
grade C 1.98 2.06% 0.04
NBRV closed up 2.06 percent on Wednesday, January 16, 2019, on 68 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical NBRV trend table...

Date Alert Name Type % Chg
Jan 16 MACD Bullish Centerline Cross Bullish 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 16 Up 3 Days in a Row Strength 0.00%
Jan 16 Up 4 Days in a Row Strength 0.00%
Jan 15 Shooting Star Candlestick Bearish 2.06%
Jan 15 Lizard Bearish Bearish Day Trade Setup 2.06%
Jan 15 Doji - Bearish? Reversal 2.06%
Jan 15 Wide Bands Range Expansion 2.06%
Jan 15 Overbought Stochastic Strength 2.06%

Older signals for NBRV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It also develops BC-7013, a topical pleuromutilin antibiotic, which has completed a Phase 1 clinical trial. Nabriva Therapeutics AG is based in Vienna, Austria.
Is NBRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.94
52 Week Low 1.12
Average Volume 512,593
200-Day Moving Average 3.1131
50-Day Moving Average 1.885
20-Day Moving Average 1.6385
10-Day Moving Average 1.838
Average True Range 0.1456
ADX 22.09
+DI 31.3239
-DI 19.8223
Chandelier Exit (Long, 3 ATRs ) 1.6032
Chandelier Exit (Short, 3 ATRs ) 1.5568
Upper Bollinger Band 2.1118
Lower Bollinger Band 1.1652
Percent B (%b) 0.86
BandWidth 57.772353
MACD Line 0.0155
MACD Signal Line -0.0438
MACD Histogram 0.0593
Fundamentals Value
Market Cap 53.14 Million
Num Shares 26.8 Million
EPS -11.49
Price-to-Earnings (P/E) Ratio -0.17
Price-to-Sales 24.71
Price-to-Book 3.00
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.12
Resistance 3 (R3) 2.12 2.08 2.09
Resistance 2 (R2) 2.08 2.05 2.08 2.08
Resistance 1 (R1) 2.03 2.02 2.06 2.03 2.08
Pivot Point 1.99 1.99 2.00 1.99 1.99
Support 1 (S1) 1.94 1.96 1.97 1.94 1.88
Support 2 (S2) 1.90 1.93 1.90 1.88
Support 3 (S3) 1.85 1.90 1.87
Support 4 (S4) 1.85